The serological diversity of serum IgG/IgA/IgM against the SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan
Yudai Kaneko, Akira Sugiyama, Toshiya Tanaka, Kazushige Fukui, Akashi Taguchi, Aya Nakayama, Kazumasa Koga, Yoshiro Kishi, Wang Daming, Chungen Qian, Fuzhen Xia, Fan He, Liang Zheng, Yi Yu, Youichiro Wada, Yoshiaki Wada, Tatsuhiko Kodama, Takeshi Kawamura
doi: https://doi.org/10.1101/2021.06.17.21258858
Yudai Kaneko
1Laboratory for Systems Biology and Medicine, Research Centre for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan
2Medical & Biological Laboratories Co., Ltd, Tokyo, Japan
Akira Sugiyama
1Laboratory for Systems Biology and Medicine, Research Centre for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan
3Isotope Science Centre, The University of Tokyo, Tokyo, Japan
Toshiya Tanaka
1Laboratory for Systems Biology and Medicine, Research Centre for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan
Kazushige Fukui
3Isotope Science Centre, The University of Tokyo, Tokyo, Japan
Akashi Taguchi
1Laboratory for Systems Biology and Medicine, Research Centre for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan
Aya Nakayama
3Isotope Science Centre, The University of Tokyo, Tokyo, Japan
Kazumasa Koga
4Department of Neurology, Nissan Tamagawa Hospital, Tokyo, Japan
Yoshiro Kishi
2Medical & Biological Laboratories Co., Ltd, Tokyo, Japan
Wang Daming
5Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Sciences, Suzhou, China
Chungen Qian
6The Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics – Hubei Bioinformatics & Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Hubei, China
Fuzhen Xia
7Reagent R&D Centre, Shenzhen YHLO Biotech Co., Ltd, Guangdong, China
Fan He
7Reagent R&D Centre, Shenzhen YHLO Biotech Co., Ltd, Guangdong, China
Liang Zheng
7Reagent R&D Centre, Shenzhen YHLO Biotech Co., Ltd, Guangdong, China
Yi Yu
7Reagent R&D Centre, Shenzhen YHLO Biotech Co., Ltd, Guangdong, China
Youichiro Wada
1Laboratory for Systems Biology and Medicine, Research Centre for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan
3Isotope Science Centre, The University of Tokyo, Tokyo, Japan
Yoshiaki Wada
4Department of Neurology, Nissan Tamagawa Hospital, Tokyo, Japan
Tatsuhiko Kodama
1Laboratory for Systems Biology and Medicine, Research Centre for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan
Takeshi Kawamura
1Laboratory for Systems Biology and Medicine, Research Centre for Advanced Science and Technology (RCAST), The University of Tokyo, Tokyo, Japan
3Isotope Science Centre, The University of Tokyo, Tokyo, Japan
Data Availability
The data that support the findings of this study are available from the corresponding author, T. K., upon reasonable request.
Posted June 25, 2021.
The serological diversity of serum IgG/IgA/IgM against the SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan
Yudai Kaneko, Akira Sugiyama, Toshiya Tanaka, Kazushige Fukui, Akashi Taguchi, Aya Nakayama, Kazumasa Koga, Yoshiro Kishi, Wang Daming, Chungen Qian, Fuzhen Xia, Fan He, Liang Zheng, Yi Yu, Youichiro Wada, Yoshiaki Wada, Tatsuhiko Kodama, Takeshi Kawamura
medRxiv 2021.06.17.21258858; doi: https://doi.org/10.1101/2021.06.17.21258858
The serological diversity of serum IgG/IgA/IgM against the SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan
Yudai Kaneko, Akira Sugiyama, Toshiya Tanaka, Kazushige Fukui, Akashi Taguchi, Aya Nakayama, Kazumasa Koga, Yoshiro Kishi, Wang Daming, Chungen Qian, Fuzhen Xia, Fan He, Liang Zheng, Yi Yu, Youichiro Wada, Yoshiaki Wada, Tatsuhiko Kodama, Takeshi Kawamura
medRxiv 2021.06.17.21258858; doi: https://doi.org/10.1101/2021.06.17.21258858
Subject Area
Subject Areas
- Addiction Medicine (330)
- Allergy and Immunology (652)
- Anesthesia (174)
- Cardiovascular Medicine (2527)
- Dermatology (211)
- Emergency Medicine (387)
- Epidemiology (12005)
- Forensic Medicine (10)
- Gastroenterology (721)
- Genetic and Genomic Medicine (3920)
- Geriatric Medicine (368)
- Health Economics (655)
- Health Informatics (2536)
- Health Policy (978)
- Hematology (353)
- HIV/AIDS (814)
- Medical Education (390)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3681)
- Nursing (205)
- Nutrition (548)
- Oncology (1915)
- Ophthalmology (558)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (244)
- Palliative Medicine (71)
- Pathology (466)
- Pediatrics (1078)
- Primary Care Research (436)
- Public and Global Health (6354)
- Radiology and Imaging (1342)
- Respiratory Medicine (847)
- Rheumatology (389)
- Sports Medicine (336)
- Surgery (427)
- Toxicology (51)
- Transplantation (180)
- Urology (157)